Seres Therapeutics Reports Second Quarter Financial Results and Provides Progress Update

Go back to Seres Therapeutics Reports Second Quarter Financial Results and Provides Progress Update
(NASDAQ: MCRB) Delayed: 5.70 -0.62 (9.81%)
Previous Close $6.32    52 Week High $44.51 
Open $6.28    52 Week Low $8.05 
Day High $6.40    P/E N/A 
Day Low $5.63    EPS $0.00 
Volume 109,373